We are live on ! Find out more
MNOV icon

MediciNova
MNOV

Fund managers haven’t disclosed any holdings of MNOV yet.

MNOV Hedge Fund Activity: Q1 2026 in Review

30 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2026, worth a combined $7.4M — down 3.9% from $7.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MNOV and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Barclays, adding an estimated $187K. The largest seller was DRW Securities, exiting entirely with an estimated $821K sold.

  • 30 institutional investors held MediciNova (MNOV) as of Q1 2026, down from 33 in Q4 2025.
  • Funds reported $7.4M of MediciNova stock for Q1 2026, down 3.9% quarter-over-quarter.
  • 5 funds opened new MediciNova positions in Q1 2026 and 7 closed out, a net change of -2 holders.
  • The largest MediciNova buyer in Q1 2026 was Barclays, an estimated $187K added.
  • The largest MediciNova seller in Q1 2026 was DRW Securities, an estimated $821K sold.

Based on aggregated 13F filings for Q1 2026.